Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
At 50, focusing on the right investments is essential. Learn which options can help you achieve your retirement goals.
19,777 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
California luxury builder Thomas James Homes announces a new growth plan under CEO Steve Schlageter, centering on pre...
May brings renewed focus on national security and market resilience. This guide identifies a top defense stock and sh...
This week, the market eyeing the Fed's preferred inflation gauge could steer the next move in stocks. If the gauge sh...
You don’t need a sprawling portfolio to retire on your terms. This story shows how a determined investor stopped cloc...
As a month-long unlock window approaches, investors face how liquidity shifts can impact SpaceX stock swings. This gu...
Three energy-focused ETFs are delivering roughly 7% yields in 2026 while avoiding K-1 tax forms. They promise simpler...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
Advance Auto Parts and Monro report stabilizing results. AAP signals margin expansion; Monro confronts guidance uncer...
Ready to put $1,000 to work in AI? This beginner-friendly guide reveals a simple, diversified approach to the best st...
Grow your portfolio with clarity. This guide compares Vanguard MEGA CAP Growth ETF (MGK) and iShares Russell 2000 ETF...
Hyperion DeFi’s Q1 2026 results shed light on how this multi-chain protocol monetizes activities across lending, liqu...